Erlotinib/gefitinibSkin ageing: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2016年 / 1622卷 / 1期

关键词：

D O I：

10.1007/s40278-016-21897-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：89 / 89

相关论文

共 50 条

[1] Erlotinib/gefitinibSkin rashes: 4 case reports
Reactions Weekly, 2014, 1532 (1) : 92 - 92
[2] Cetuximab/erlotinib/gefitinibSkin eruptions, treated with roxithromycin: 9 case reports
Reactions Weekly, 2013, 1452 (1) : 11 - 11
[3] Erlotinib/gefitinibSkin rash, xerosis and pruritus: case report
Reactions Weekly, 2014, 1487 (1) : 18 - 18
[4] GefitinibSkin disorders: 11 case reports
Reactions Weekly, 2017, 1650 (1) : 150 - 150
[5] Erlotinib/panitumumabTrichomegaly: 3 case reports
Reactions Weekly, 2013, 1443 (1) : 15 - 15
[6] Erlotinib/gefitinibDevelopment of resistance to erlotinib and gefitinib: 3 case reports
Reactions Weekly, 2018, 1730 (1) : 136 - 136
[7] Erlotinib/gefitinibSevere hepatotoxicity: 3 case reports
Reactions Weekly, 2016, 1603 (1) : 115 - 115
[8] Erlotinib/osimertinibDrug resistance: 3 case reports
Reactions Weekly, 2021, 1874 (1) : 106 - 106
[9] Erlotinib/gefitinibAcneiform eruption: 3 case reports
Reactions Weekly, 2013, 1441 (1) : 15 - 15
[10] Erlotinib/gefitinibPurpuric drug eruption: 3 case reports
Reactions Weekly, 2020, 1786 (1) : 80 - 80

← 1 2 3 4 5 →